USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT
Germany
02793811.7
Filed on 2002-10-22
02793811.7
Filed on 2002-10-22
The Use Of Leptin For Treating Human Lipoatrophy
Switzerland
02793811.7
Filed on 2002-10-22
02793811.7
Filed on 2002-10-22
Hepatitis C Virus Culture System
US Application 12/895,518
Filed on 2010-09-30
Filed on 2010-09-30
Purine Derivatives As A3 Adenosine Receptor-Selective Agonists
US Patent 8,735,407
Filed on 2010-11-01
Filed on 2010-11-01
Purine Derivatives As A3 Adenosine Receptor-Selective Agonists
European Patent
09728154.7
Filed on 2009-03-24
09728154.7
Filed on 2009-03-24
Purine Derivatives As A3 Adenosine Receptor-Selective Agonists
Canada
2720037
Filed on 2009-03-24
2720037
Filed on 2009-03-24
Purine Derivatives As A3 Adenosine Receptor-Selective Agonists
Australia
2009231978
Filed on 2009-03-24
2009231978
Filed on 2009-03-24
Novel CoFactor Modulates Steroid Receptor Activities
US Application 12/899,356
Filed on 2005-02-25
Filed on 2005-02-25
The Use Of Leptin For Treating Human Lipoatrophy
Japan
2010-137501
Filed on 2010-06-16
2010-137501
Filed on 2010-06-16